PL1625163T3 - Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43 - Google Patents
Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43Info
- Publication number
- PL1625163T3 PL1625163T3 PL04732278T PL04732278T PL1625163T3 PL 1625163 T3 PL1625163 T3 PL 1625163T3 PL 04732278 T PL04732278 T PL 04732278T PL 04732278 T PL04732278 T PL 04732278T PL 1625163 T3 PL1625163 T3 PL 1625163T3
- Authority
- PL
- Poland
- Prior art keywords
- amino acids
- monoclonal antibody
- antibody binding
- probnp
- native probnp
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 150000001413 amino acids Chemical class 0.000 title 1
- 102100036836 Natriuretic peptides B Human genes 0.000 abstract 5
- 101710187802 Natriuretic peptides B Proteins 0.000 abstract 5
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 210000004408 hybridoma Anatomy 0.000 abstract 1
- 238000011895 specific detection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03010591 | 2003-05-12 | ||
PCT/EP2004/005091 WO2004099252A1 (en) | 2003-05-12 | 2004-05-12 | Method of detecting native probnp with amonoclonal antibody binding to the amino acids 38-44 |
EP04732278A EP1625163B8 (en) | 2003-05-12 | 2004-05-12 | Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-43 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1625163T3 true PL1625163T3 (pl) | 2012-01-31 |
Family
ID=33427054
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04732282T PL1625164T3 (pl) | 2003-05-12 | 2004-05-12 | Sposób wykrywania proBNP z użyciem przeciwciała monoklonalnego wiążącego się z aminokwasami 42-46 |
PL04732278T PL1625163T3 (pl) | 2003-05-12 | 2004-05-12 | Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43 |
PL10172014T PL2256132T3 (pl) | 2003-05-12 | 2004-05-12 | Sposób wykrywania proBNP z zastosowaniem przeciwciała monoklonalnego |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04732282T PL1625164T3 (pl) | 2003-05-12 | 2004-05-12 | Sposób wykrywania proBNP z użyciem przeciwciała monoklonalnego wiążącego się z aminokwasami 42-46 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10172014T PL2256132T3 (pl) | 2003-05-12 | 2004-05-12 | Sposób wykrywania proBNP z zastosowaniem przeciwciała monoklonalnego |
Country Status (16)
Country | Link |
---|---|
US (4) | US7264938B2 (pl) |
EP (4) | EP2949669A1 (pl) |
JP (4) | JP5128125B2 (pl) |
KR (2) | KR100857752B1 (pl) |
CN (3) | CN100497393C (pl) |
AT (2) | ATE522546T1 (pl) |
AU (1) | AU2004235974B2 (pl) |
BR (1) | BRPI0410261B8 (pl) |
CA (2) | CA2522378C (pl) |
DK (3) | DK1625163T3 (pl) |
ES (3) | ES2372282T3 (pl) |
HK (1) | HK1097855A1 (pl) |
HU (1) | HUE025169T2 (pl) |
MX (1) | MXPA05011826A (pl) |
PL (3) | PL1625164T3 (pl) |
WO (2) | WO2004099252A1 (pl) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2843396B1 (fr) * | 2002-08-07 | 2005-04-15 | Bio Rad Pasteur | Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque |
DK1625163T3 (da) * | 2003-05-12 | 2011-12-05 | Hoffmann La Roche | Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43 |
US20070037208A1 (en) * | 2003-05-29 | 2007-02-15 | Foote Robert S | Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
DE10355731A1 (de) | 2003-11-28 | 2005-06-30 | Roche Diagnostics Gmbh | Analytischer Sandwichtest zur Bestimmung von NT-proBNP |
DE602005001299T2 (de) * | 2004-07-07 | 2008-02-07 | Roche Diagnostics Gmbh | Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes |
AT500800B1 (de) * | 2004-09-08 | 2008-07-15 | Biomedica Medizinprodukte Gmbh | Verfahren zur bestimmung von probnp |
CN101636656A (zh) | 2007-01-25 | 2010-01-27 | 霍夫曼-拉罗奇有限公司 | Igfbp-7在心力衰竭评估中的用途 |
KR100836322B1 (ko) * | 2007-08-31 | 2008-06-09 | 현대자동차주식회사 | 차량용 흡음재 제작장치 및 방법 |
US9482677B2 (en) | 2008-02-27 | 2016-11-01 | Scios Inc. | Method, composition and device for sampling natriuretic peptides in a biological fluid |
JP5524182B2 (ja) | 2008-04-30 | 2014-06-18 | エフ.ホフマン−ラ ロシュ アーゲー | 心不全の評価におけるsfrp−3の使用 |
EP2460015B1 (en) | 2009-07-27 | 2014-08-20 | Roche Diagnostics GmbH | Use of mimecan in the assessment of heart failure |
EA201290311A1 (ru) * | 2009-11-13 | 2012-12-28 | БиДжи МЕДИСИН, ИНК. | Факторы риска и прогнозирование инфаркта миокарда |
AU2011285694B2 (en) | 2010-08-04 | 2014-12-18 | Idexx Laboratories, Inc. | Detection of degradation products of canine NT-proBNP |
WO2012166918A1 (en) | 2011-05-31 | 2012-12-06 | Idexx Laboratories, Inc. | DETECTION OF DEGRADATION PRODUCTS OF FELINE NT-proBNP |
WO2013042603A1 (ja) * | 2011-09-20 | 2013-03-28 | コニカミノルタホールディングス株式会社 | 検体希釈用液、それを用いたキットおよび蛍光測定方法 |
US20140273273A1 (en) | 2012-11-01 | 2014-09-18 | Christie Mitchell Ballantyne | Biomarkers to improve prediction of heart failure risk |
CN103304665A (zh) * | 2013-05-21 | 2013-09-18 | 上海贝西生物科技有限公司 | 一种抗氨基末端脑利钠肽前体单克隆抗体及其应用 |
JP6682445B2 (ja) * | 2014-10-10 | 2020-04-15 | 松森 昭 | 心不全患者の検出方法、心疾患の識別方法、心不全の検査試薬、心不全の検査キット、心不全を検出するための装置及び心不全を検出するためのプログラム |
EP3360570A1 (en) | 2017-02-13 | 2018-08-15 | Roche Diagnostics GmbH | Antibodies recognizing genetic variants |
US11549940B2 (en) | 2017-10-02 | 2023-01-10 | Otsuka Pharmaceutical Co., Ltd. | Method for detecting analyte |
US20210148934A1 (en) * | 2018-04-13 | 2021-05-20 | Kyoritsu Seiyaku Corporation | Method of detecting heart failure, device for detecting heart failure, sandwich immunoassay method, and combination of antibodies |
CN108752480B (zh) * | 2018-05-30 | 2022-03-29 | 中元汇吉生物技术股份有限公司 | 一种免疫原组合物、其制备方法及其用途 |
US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
CN111487222B (zh) * | 2019-01-28 | 2023-11-14 | 上海乐合生物科技有限公司 | 一种检测bnp的spr芯片的制备方法 |
EP4014041A1 (en) | 2019-08-13 | 2022-06-22 | Gentian AS | Highly sensitive particle enhanced assay for the quantification of nt-probnp |
JP7650966B2 (ja) * | 2020-09-30 | 2025-03-25 | エフ. ホフマン-ラ ロシュ アーゲー | 心房細動の評価における、循環中の総NT-proBNP(グリコシル化および非グリコシル化NT-proBNP)ならびにそのNT-proBNP(非グリコシル化NT-proBNP)との比率 |
CN112986586A (zh) * | 2021-02-20 | 2021-06-18 | 广东菲鹏生物有限公司 | 一种氨基末端脑尿钠肽检测方法和试剂盒 |
CN112964885B (zh) * | 2021-02-20 | 2022-11-11 | 广东菲鹏生物有限公司 | 一种氨基末端脑尿钠肽检测方法和试剂盒 |
CN118119849A (zh) | 2021-10-01 | 2024-05-31 | 挪威金田有限公司 | 测定样品中N末端激素原BNP(NT-proBNP)浓度的新方法 |
CN118871785A (zh) | 2022-03-18 | 2024-10-29 | 豪夫迈·罗氏有限公司 | 用于2型与1型急性心肌梗死的早期辨别的肌钙蛋白标志物组合 |
EP4493937A1 (en) | 2022-03-18 | 2025-01-22 | Roche Diagnostics GmbH | Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
WO2024219421A1 (ja) * | 2023-04-19 | 2024-10-24 | 栄研化学株式会社 | NT-proBNPに対する抗体、これを用いたNT-proBNP検出方法、並びに、NT-proBNP検出に用いるための組成物及びキット |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3445816C1 (de) | 1984-12-15 | 1986-06-12 | Behringwerke Ag, 3550 Marburg | Flaechenfoermiges diagnostisches Mittel |
JP2665850B2 (ja) | 1991-11-14 | 1997-10-22 | 塩野義製薬株式会社 | hBNPのC端を認識するモノクロ−ナル抗体 |
GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
GB9827348D0 (en) | 1998-12-12 | 1999-02-03 | Univ Leicester | Natriuretic peptide |
RU2218568C2 (ru) | 1999-01-29 | 2003-12-10 | Роше Диагностикс Гмбх | Способ обнаружения n-концевого про-мнп |
US20030219734A1 (en) | 2001-04-13 | 2003-11-27 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
US20040096919A1 (en) * | 2002-11-18 | 2004-05-20 | Michelle Davey | Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP |
DK1625163T3 (da) * | 2003-05-12 | 2011-12-05 | Hoffmann La Roche | Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43 |
-
2004
- 2004-05-12 DK DK04732278.9T patent/DK1625163T3/da active
- 2004-05-12 AU AU2004235974A patent/AU2004235974B2/en not_active Expired
- 2004-05-12 ES ES04732278T patent/ES2372282T3/es not_active Expired - Lifetime
- 2004-05-12 CN CNB200480012494XA patent/CN100497393C/zh not_active Expired - Lifetime
- 2004-05-12 KR KR1020057021327A patent/KR100857752B1/ko not_active Expired - Lifetime
- 2004-05-12 CA CA2522378A patent/CA2522378C/en not_active Expired - Lifetime
- 2004-05-12 PL PL04732282T patent/PL1625164T3/pl unknown
- 2004-05-12 JP JP2006505419A patent/JP5128125B2/ja not_active Expired - Lifetime
- 2004-05-12 MX MXPA05011826A patent/MXPA05011826A/es active IP Right Grant
- 2004-05-12 CN CNA2004800124973A patent/CN1784425A/zh active Pending
- 2004-05-12 ES ES04732282T patent/ES2369008T3/es not_active Expired - Lifetime
- 2004-05-12 EP EP15161853.5A patent/EP2949669A1/en not_active Ceased
- 2004-05-12 DK DK04732282.1T patent/DK1625164T3/da active
- 2004-05-12 KR KR1020087000782A patent/KR20080011467A/ko not_active Ceased
- 2004-05-12 WO PCT/EP2004/005091 patent/WO2004099252A1/en active Application Filing
- 2004-05-12 PL PL04732278T patent/PL1625163T3/pl unknown
- 2004-05-12 EP EP04732278A patent/EP1625163B8/en not_active Expired - Lifetime
- 2004-05-12 JP JP2006505418A patent/JP4430066B2/ja not_active Expired - Lifetime
- 2004-05-12 BR BRPI0410261A patent/BRPI0410261B8/pt not_active IP Right Cessation
- 2004-05-12 DK DK10172014.2T patent/DK2256132T3/en active
- 2004-05-12 EP EP04732282A patent/EP1625164B1/en not_active Expired - Lifetime
- 2004-05-12 CN CN2010101190838A patent/CN101967190A/zh active Pending
- 2004-05-12 HU HUE10172014A patent/HUE025169T2/en unknown
- 2004-05-12 AT AT04732278T patent/ATE522546T1/de active
- 2004-05-12 WO PCT/EP2004/005092 patent/WO2004099253A1/en active Search and Examination
- 2004-05-12 EP EP10172014.2A patent/EP2256132B1/en not_active Expired - Lifetime
- 2004-05-12 ES ES10172014.2T patent/ES2548327T3/es not_active Expired - Lifetime
- 2004-05-12 AT AT04732282T patent/ATE517124T1/de active
- 2004-05-12 PL PL10172014T patent/PL2256132T3/pl unknown
- 2004-05-12 CA CA2522747A patent/CA2522747C/en not_active Expired - Lifetime
-
2005
- 2005-11-10 US US11/271,138 patent/US7264938B2/en not_active Expired - Lifetime
- 2005-11-10 US US11/271,651 patent/US7264939B2/en not_active Expired - Lifetime
-
2006
- 2006-12-05 US US11/634,286 patent/US7807380B2/en not_active Expired - Lifetime
- 2006-12-22 US US11/644,565 patent/US7811770B2/en not_active Expired - Lifetime
-
2007
- 2007-02-28 HK HK07102250.4A patent/HK1097855A1/xx not_active IP Right Cessation
-
2009
- 2009-09-04 JP JP2009204610A patent/JP4834136B2/ja not_active Expired - Lifetime
-
2012
- 2012-10-04 JP JP2012222436A patent/JP5649631B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1625163T3 (pl) | Sposoby wykrywania proBMP przeciwciałem monoklonalnym wiążącym się z aminokwasami 38-43 | |
ATE486093T1 (de) | Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt | |
ATE440868T1 (de) | Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen | |
MXPA05010827A (es) | Determinacion de un peptido parcial de la region mid de la proadrenomedulina en fluidos biologicos para propositos de diagnostico, e inmunoensayos para la conduccion de una identificacion de este tipo. | |
DK1092155T3 (da) | Fremgangsmåde til tidlig diagnose af carcinomer | |
JP2007525427A5 (pl) | ||
DK1151304T3 (da) | Fremgangsmåde til påvisning af N-terminalt proBNP | |
ATE335763T1 (de) | Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden | |
WO2009075376A1 (ja) | 抗オフロキサシンモノクローナル抗体、これを用いたオフロキサシンの免疫学的測定方法 | |
DE60333471D1 (de) | Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp | |
WO2008125733A8 (en) | Immunoassay for quantification of an unstable antigen selected from bnp and probnp | |
WO2009054091A1 (ja) | ガストリン放出ペプチド前駆体に対する抗体及びその使用 | |
WO2003027149A1 (fr) | Anticorps et utilisation de ce dernier | |
WO2009044561A1 (ja) | 抗proNT/NMNモノクローナル抗体 | |
WO2009016734A1 (ja) | 軽度認知機能障害の検定方法 | |
SE0202702L (sv) | Immunotest för specifik bestämning av SCCA isoformer | |
EP1359161A3 (en) | Monoclonal antibody specific to tartrate-resistant acid phosphatase 5b and use thereof | |
WO2004029094B1 (en) | Monoclonal antibody specific for human mitochondrial adenylate kinase isozyme 3 | |
EP1483292A4 (en) | MONOCLONAL ANTIBODIES WITH CROSS-REACTION AGAINST BACTERIAL COLLAGEN BINDING PROTEINS | |
ATE405646T1 (de) | Ein verfahren zum auffinden vom prostatakrebs | |
WO2003027150A1 (fr) | Anticorps et son utilisation | |
TW200720655A (en) | ELISA kit for diagnosting infectious bursal disease (IBD) and method using the same |